multiple sclerosis

The problem of multiple sclerosis demands a multidisciplinary approach, so my clinical and research work made me face a lot of its serious issues: epidemiology, neurogenetics, neuroimmunology, diagnostics, treatment, rehabilitation, and social care.

Abstract: Objective: To report the results of a 24-month extension of a phase II trial assessing the efficacy, safety, and tolerability of the once-daily oral sphingosine-1-phosphate receptor modulator, fingolimod (FTY720), in relapsing multiple sclerosis (MS).
Methods: In the randomized, double-blind,… Continue Reading

In April 2011, the EFNS together with ENS and ECTRIMS, have published this important statement. What is the follow-up?
https://www.efns.org/uploads/media/CCSVI_in_MS_ECTRIMS_EFNS_ENS_02.pdf Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis – From “The Big Idea” to “The Perfect Crime”? By Christos Krogias,… Continue Reading

In the last six months, the EFNS Scientific Fellowship programme gave me the opportunity to work as visiting scientist in the Laboratory for Molecular Neurology, coordinated by Prof. Dr. Orhan Aktas, at the Department of Neurology of the Heinrich-Heine University, Düsseldorf, Germany, chaired by Prof. Dr. Hans-Peter Hartung.

Deadline of application: 31 January 2012 This year’s Spring School will take place from 10-13 May 2012.
The topics covered will be: Movement disorders; Multiple sclerosis; Consciousness, coma, intensive care in neurology and Neurology in the world – present state… Continue Reading

Abstract Background: The spectrum of disorders of the brain is large, covering hundreds of disorders that are listed in either the mental or neurological disorder chapters of the established international diagnostic classification systems. These disorders have a high prevalence as… Continue Reading